Should You Buy the Hyperliquid Cryptocurrency or the Stock?

Hyperliquid’s DEX processed $181.6 billion in perpetuals volume over the 30 days ending May 1, and its protocol directs about 97% of trading fees into HYPE buybacks and burns. The article argues HYPE is the more direct way to gain exposure versus Hyperliquid Strategies, which held 17.6 million HYPE and $112.6 million in cash as of early 2026 but faces dilution risk from share issuance and token unlocks. Overall tone is cautiously bullish on the token, while noting both assets remain highly risky and unproven.

Analysis

The key market distinction is not “token vs stock,” but direct vs mediated reflexivity. The token is the cleaner expression of protocol growth because fee generation mechanically supports buybacks, while the stock adds an extra balance-sheet layer that can either dampen or amplify returns depending on issuance discipline. In a fast-growing adoption phase, that difference matters: the token should outperform on a percentage basis if volumes keep compounding, because every incremental dollar of fees translates more directly into scarcity.

The hidden second-order risk is supply overhang, not just demand volatility. With a large fraction of supply still locked and monthly unlocks continuing for years, the market is effectively running a rolling test of whether protocol buybacks can absorb structural dilution without compressing price. If trading activity stalls for even a few months, the market may re-rate the token from “cash-flowing scarcity asset” to “high-beta unlock story,” which is usually a sharp multiple compression event rather than a gradual one.

For the listed wrapper, the real issue is governance optionality. If management uses equity issuance opportunistically into strength and buybacks into weakness, common shareholders can still win, but only if the discount to underlying token NAV remains wide enough to offset dilution risk. That makes the stock more interesting as a trading vehicle around sentiment dislocations than as a pure long-term compounder versus the token.

The contrarian takeaway is that consensus may be underestimating how quickly competitive pressure in perps can erode the fee pool. In this part of crypto, moat duration is often shorter than narratives imply; if volume leadership slips, the buyback engine weakens immediately. That creates a binary setup over the next 3-12 months: either Hyperliquid remains the liquidity center and both instruments work, or the market discovers the scarcity mechanism is less powerful than the current growth curve assumes.

Key Decisions for Investors

• Prefer long HYPE over the listed treasury wrapper on a 3-6 month view; the cleaner exposure to fee-driven buybacks should carry higher upside if perp volumes remain strong, but size modestly because unlocks create a constant dilution headwind.
• Trade the stock only on large NAV dislocations: buy PURR when the market discount to look-through HYPE holdings widens materially and sell/trim into sharp rallies, since issuance risk makes it a mean-reverting vehicle rather than a core hold.
• Use a pair trade: long HYPE / short PURR for a relative-value expression of direct protocol exposure versus mediated balance-sheet exposure; the spread should favor HYPE if trading activity stays elevated over the next 1-2 quarters.
• For higher-conviction but capped-risk exposure, consider a small long call structure in HYPE with 3-6 month tenor rather than spot, because the main catalyst is sustained volume growth while the primary risk is a sudden drawdown from unlocks or fee deceleration.
• If perps volume rolls over for 4-6 consecutive weeks, reduce exposure quickly; that would be the earliest signal that the buyback mechanism is no longer offsetting supply growth.